Atlas Trials

Bexagliflozin Efficacy and Safety Trial

Clinical trial NCT02558296 · COMPLETED

Trial details

NCT number
NCT02558296
Sponsor
Theracos
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2015-10-01
Primary completion
2018-08-01
Enrollment
1700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.